Table 3.
UBE2O immunohistochemical staining of prostate cancer for radical prostatectomy due to prostate cancer.
| UBE20 | Total (n = 355) |
p Value | |||
|---|---|---|---|---|---|
| 1 (n = 120) | 2 (n = 154) | 3 (n = 81) | |||
| Age | 65 (60, 68) | 65 (60, 69) | 66 (62, 72) | 65 (61, 69) | 0.029 |
| PSA | <0.001 | ||||
| <10 | 28 | 45 | 39 | 112 | |
| 10–20 | 92 | 109 | 42 | 243 | |
| >20 | 0 | 0 | 0 | 0 | |
| Gleason sum | 0.168 | ||||
| ≤6 | 17 | 18 | 8 | 43 | |
| 7 | 52 | 67 | 25 | 144 | |
| 8–10 | 51 | 69 | 48 | 168 | |
| Pathological stage | <0.001 | ||||
| ≤T2 | 25 | 42 | 39 | 106 | |
| ≥T3 | 95 | 112 | 42 | 249 | |
| Seminal vesicle invasion | 0.772 | ||||
| Negative | 101 | 126 | 65 | 292 | |
| Positive | 19 | 27 | 16 | 62 | |
| Lymph node involvement | 0.015 | ||||
| Negative | 120 | 149 | 75 | 344 | |
| Positive | 0 | 5 | 5 | 10 | |
| Surgical margin # | 0.555 | ||||
| Negative | 19 | 40 | 35 | 94 | |
| Positive | 12 | 32 | 35 | 79 | |
UBE2O grade—0: negative, 1: weak, 2: moderate, 3: strong. Age was expressed as Median (lower quadrant, upper quadrant). The number of UBE2O immunohistochemical staining of prostate cancer could be evaluated in 355 from our hospital from 200 patients with prostate cancer of our hospital and 180 from purchased TMA. # The number of surgical margin could be evaluated in only 200 of our hospital from 382 patients with prostate cancer excluding purchased TMA. Out of 202 patients with prostate cancer of our hospital, the 173 patients could be evaluated with UBE2O immunohistochemical staining.